Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study
Richard Rupp, Gary Joseph Luckasen, Judith Lee Kirstein, Jorge E. Osorio, Joseph D. Santangelo, Marsha Raanan, Mary Kathryn Smith, Derek Wallace, Gilad S. Gordon, Dan T. Stinchcomb
Dive into the research topics of 'Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study'. Together they form a unique fingerprint.